Browse > Article

The Effects of Hesperidin on the Proliferation and Activity of Bone Cells  

Bae, Moon-Seo (Dept. of Dental Pharmacology, School of Dentistry, Dankook University)
Ko, Seon-Yle (Dept. of Oral Biochemistry, School of Dentistry, Dankook University)
Kim, Se-Won (Dept. of Dental Pharmacology, School of Dentistry, Dankook University)
Publication Information
International Journal of Oral Biology / v.31, no.4, 2006 , pp. 119-125 More about this Journal
Abstract
The importance of phytoestrogens to human health is currently being actively investigated. Hesperidin, abundantly found in citrus fruits, is known to possess antioxidant, anticancer, and anti-inflammatory effects. Recently, it has been reported that hesperidin inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. In our study, to determine the possible role of hesperidin in the regulation of bone metabolism, we observed the effects of hesperidin on the proliferation and activity of osteoblasts, as well as the effects of hesperidin on osteoclast generation and activity. We observed that, when treated with hesperidin, the number and viability of osteoblastic cells increased, alkaline phosphatase (ALP) activity of osteoblastic cells increased, and osteoprotegerin (OPG) secretion from MG63 cells decreased. Hesperidin treatment had no effect on the osteoclast generation and activity in the bone marrow cell culture, but decreased the number and resorptive activity of osteoclasts generated from RAW/264.7 cells. Taken together, these results indicate that hesperidin increases the proliferation and activity of osteoblasts, while inhibiting generation and activity of osteoclasts. Although the precise role of hesperidin remains to be elucidated, our study suggests that it is one of the important modulators of bone metabolism.
Keywords
hesperidin; osteoclast; osteoblast; osteoprotegerin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Adlercreutz, H., Hamalainen, E., Gorbach, S. and Goldin B.: Dietary phytoestrogens and the menopause in Japan. Lancet 339:1233, 1992   DOI   ScienceOn
2 Anderson, J.W., Johnstone, B.M. and Cook-Newell, M.E.: Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333:276-282, 1995   DOI   ScienceOn
3 Anderson, J.J., Ambrose, W.W. and Garner, S.C.: Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc. Soc. Exp. Biol. Med. 217:345-350, 1998
4 Kurzer, M.S. and Xu, X.: Dietary phytoestrogens. Annu. Rev. Nutr. 17:353-381, 1997   DOI   ScienceOn
5 Monforte, M.T., Trovato, A., Kirjavainen, S., Forestieri, A.M., Galayi, E.M. and Lo Curto, R.B.: Biological effects of hesperidin, a Citrus flavonoid: hypolipidemic activity on experimental hypercholesterolemia in rat. Farmaco 50:595- 599, 1995
6 Rodan, G.A.: Emerging therapies in osteoporosis. Annu. Rep. Med. Chem. 29:275-285, 1994   DOI
7 Aboobaker, V.S., Balgi, A.D. and Bhattacharya, R.K.: In vivo effect of dietary factors on the molecular action of aflatoxin B1: role of non-nutrient phenolic compounds on the catalytic activity of liver fraction. In Vivo 8:1095-1098, 1994
8 Sugimoto, E. and Yamaguchi, M.: Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int. J. Mol. Med. 5515-520, 2000
9 Emin, J.A., Oliveira, A.B. and Lapa, A.J.: Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid, hesperidin, and the isoflavonoids, quartin and claussequinone, in rats and mice. J. Pharm. Pharmacol. 46:118-122, 1994   DOI   ScienceOn
10 Recker, R.R.: Current therapy for osteoporosis. J. Clin. Endocrinol. Metab. 76:14-16, 1993   DOI
11 Bellows, C.G., Aubin, J.E. and Heersche, J.N.: Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. Bone Miner.14:27-40, 1991   DOI   ScienceOn
12 Heaney, R.P., Recker, P.R. and Saville, P.D.: Menopausal changes in calcium balance performance. J. Lab. Clin. Med. 92:953-963, 1978
13 Korach, K.S., Migliaccio, S. and Davis, V.L.: Estrogens. In Principles of pharmacology - Basic concepts and clinical applications, edited by Munson, P.L., pp. 809-825, Chapman and Hall, New York, 1994
14 Messina, M.J., Persky, V., Setchell, K.D.R. and Barnes, S.: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21:113-131, 1994   DOI   ScienceOn
15 Muhlbauer, R.C. and Li, F.: Effect of vegetables on bone metabolism. Nature 401:343-344, 1999   DOI   ScienceOn
16 Riggs, B.L. and Melton III, L.J.: The prevention and treatment of osteoporosis. N. Eng. J. Med. 327:620-627, 1992   DOI   ScienceOn
17 Ishimi, Y., Arai, N., Wang, X.X., Wu, J., Umegaki, K., Miyaura, C., Takada, A. and Ikegami, S.: Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem. Biophys. Res. Commun. 274:697-701, 2000   DOI   ScienceOn
18 Setchell, K.D.R.: Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 68:1333S-1346S, 1998   DOI
19 Arjmandi, B.H., Alekel, L., Hollis, B.W., Amin, D., Stacewicz-Sapuntzakis, M., Guo, P. and Kukreja, S.C.: Dietary soy protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 126:161-167, 1996   DOI
20 Bennetts, H., Underwood, E.J. and Shier, F.L.: A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust. Vet. J. 22:2-11, 1946   DOI
21 Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H.L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P. and Boyle, W.J.: Osteoprotegerin; a novel secreted protein involved in the regulation of bone density. Cell 89:309-319, 1997   DOI   ScienceOn
22 Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., BuBose, R.F., Cosman, D. and Galibert, L.: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function. Nature 390:175-179, 1997   DOI   ScienceOn
23 Farley, J.R. and Baylink, D.: Skeletal alkaline phosphatase activity as a bone formation index in vitro. Metabolism 35:563-571, 1986   DOI   ScienceOn
24 Ingold, P., Kneissel, M., Muhlbauer, R.C. and Gasser, J.A.: Extracts from onion prevent tibial cortical and cancellous bone loss induced by a high phosphate/low protein diet in aged retired breeder rats. Bone 23:S387, 1998
25 Hsu, H., Lacey, D.L., Dunstan, C.R., Solovyev, I., Colombero, A., Timms, E., Tan, H.L., Elliott, G., Kelley, M.J., Sarosi, I., Wang, L., Xia, X.L., Elliott, R., Chiu, L., Black, T., Scully, S., Capparelli, C., Morony, S., Shimamoto, G., Bass, M.B. and Boyle, W.J.: Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96:3540-3545, 1999
26 Fanti, O., Faugere, M.C., Gang, Z., Schmidt, J., Cohen, D. and Malluche, H.H.: Sys-tematic administration of genistein partially prevents bone loss in ovariectomi-zed rats in a nonestrogen-like mechanism. Am. J. Clin. Nutr. 68(Suppl): 1517S. 1998
27 Ishimi, Y., Miyaura, C., Ohmura, M., Onoe, Y., Sato, T., Uchiyama, Y., Ito, M., Wang, X.X., Suda, T. and Ikegami, S.: Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140:1893-1900, 1999   DOI   ScienceOn
28 Chiba, H., Uehara, M., Wu, J., Wang, X., Masuyama, R., Suzuki, K., Kanazawa, K. and Ishimi, Y.: Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J. Nutr. 133:1892- 1897, 2003
29 Genant, H.K., Baylink, D.J. and Gallagher, J.C.: Estrogens in the prevention of osteoporosis in postmenopausal women. Am. J. Obstet. Gynecol. 161:1842-1846. 1989   DOI   ScienceOn
30 Lee, S.H., Jeong, T.S., Park, Y.B., Kwon, Y.K., Choi, M.S. and Bok, S.H.: Hypocholesterolemic effect of hesperidin mediated by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A: cholesterol acyltransferase in rats fed high-cholesterol diet. Nutr. Res. 19:1245-1258, 1999   DOI   ScienceOn
31 Damon, P., Flandre, O., Michel, F., Perdrix, L., Labrid, C. and Crastes de Paulet, A.: Effect of chronic treatment with a purified flavonoid fraction on inflammatory granuloma in the rat. Study of prostaglandin $E_{2}$ and $F_{2a}$ and thromboxane $B_{2}$ release and histological changes. Arzneimittel-Forschung 37:1149-1153, 1987
32 Kong, Y.Y., Yasuda, H., Sarosi, I.,Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dubstan, C., Lacey, D.L., Mak, T.W., Boyle, W.J. and Penninger, J.M.: OPGL is a key regulator of osteoclastogenesis, lymphocyte develop- ment and lymph node organogenesis. Nature 397:315-323, 1999   DOI   ScienceOn